Curium Announces First Commercial Doses of PYLCLARI for Patients with Prostate Cancer in Poland
PYLCLARI® provides solutions to a wider patient group across Poland where there…
DataGavel Announces Full Acquisition by Renvent Holdings as Platform Emerges as the Defense Bars Advantage
ROSWELL, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- DataGavel, the LegalTech platform…
Mawson Infrastructure Group Inc. Announces Compliance with Nasdaq Continued Listing Requirements
December 22, 2025 14:05 ET | Source: Mawson Infrastructure Group Inc. MIDLAND,…
SOS Limited Announces Development of Tier III Modular Data Center at Longfellow Ranch, Texas
NEW YORK, Dec. 22, 2025 /PRNewswire/ -- SOS Limited (NYSE: SOS) ("SOS"…
Velo Announces Integration of USD1 With World Liberty Financial to Strengthen PayFi Infrastructure Across Asia
SINGAPORE, Dec. 22, 2025 /PRNewswire/ -- Velo, a PayFi infrastructure protocol focused on…
Bitmine Immersion (BMNR) Announces ETH Holdings Reach 4.066 Million Tokens, and Total Crypto and Total Cash Holdings of $13.2 Billion
Bitmine now owns 3.37% of the ETH token supply, two-thirds of the…
Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype
The secondary analysis of the PACE trial highlights the value of counting…
Biosplice Therapeutics Announces First Patient Dosed in InvestigatorInitiated Phase 1 Clinical Trial of Cirtuvivint and Olaparib in BRCA/HRD PlatinumResistant Ovarian Cancer
SAN DIEGO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”),…
Alvotech announces European launch of first-in-market biosimilar to Simponi (golimumab) globally by partner Advanz Pharma
Introduction of AVT05 supported by NHS England tender award in the United…
MMA Announces SMARTIES X Global 2025 Winners: Honoring Marketing That Drives Global Impact
NEW YORK, Dec. 19, 2025 /PRNewswire/ -- The Marketing + Media Alliance…
